Asceneuron will participate in the 22nd Annual Biotech in Europe Forum for global partnering and investment (BEF), being held on September 21st-22nd, 2022 in Basel.

Asceneuron’s CEO and founder Dirk Beher shared his views on the remaining challenges of tackling diseases like PSP and Alzheimer’s disease in an article by George Underwood in Pharmaphorum.